We are a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Unless specifically noted otherwise, as used herein, the terms “we,” “us” and “our” refer to Cornerstone Therapeutics Inc. We are actively seeking to expand our portfolio of products for these markets through the acquisition of companies and products and through internal development.
Company profile
Ticker
CRTX
Exchange
Website
CEO
Casey Crawford Lynch
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Critical Therapeutics Inc
SEC CIK
Corporate docs
IRS number
43523569
Latest filings (excl ownership)
15-12G
Securities registration termination
14 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 14
RW
Registration withdrawal request
5 Feb 14
25-NSE
Exchange delisting
4 Feb 14
Latest ownership filings
SC 13D/A
Cornerstone Therapeutics Inc
7 Feb 14
SC 13D/A
Cornerstone Therapeutics Inc
4 Feb 14
SC 13D/A
Cornerstone Therapeutics Inc
20 Sep 13
SC 13D/A
Cornerstone Therapeutics Inc
16 Sep 13
SC 13D/A
Chiesi Farmaceutici SpA
19 Feb 13
SC 13D/A
Chiesi Farmaceutici SpA
9 Jul 12
SC 13D/A
Chiesi Farmaceutici SpA
17 Apr 12
SC 13D/A
Cornerstone BioPharma Holdings, Ltd.
5 Apr 12
SC 13D/A
Cornerstone BioPharma Holdings, Ltd.
21 Dec 10
SC 13D/A
Chiesi Farmaceutici SpA
20 Dec 10